Get the Stockscreener App
16.85
786.84%
14.95
After Hours:
17.70
0.85
+5.04%
Atyr Pharma Inc Stock (LIFE) Forecast
The Atyr Pharma Inc (LIFE) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.6171, representing a -90.40% decrease from the current price of $16.85. The highest analyst price target is $2.8294, and the lowest is $0.4048.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LIFE Price Target
Average 4.6958
(-72.13% Downside)
Is Atyr Pharma Inc (LIFE) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 0.00 | Neutral |
| STOCH(9,6) | 0.00 | Buy |
| STOCHRSI(14) | 0.00 | Neutral |
| MACD(12,26) | 0.00 | Neutral |
| ADX(14) | 0.00 | Neutral |
| William %R | -100.00 | Buy |
| CCI(14) | 0.00 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.685
Buy
|
0.00
Buy
|
| MA20 |
0.8425
Buy
|
0.00
Buy
|
| MA50 |
0.337
Buy
|
0.00
Buy
|
| MA100 |
0.1685
Buy
|
0.00
Buy
|
| MA200 |
0.0843
Buy
|
0.00
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, LIFE could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 0 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on LIFE, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 0 indicates that LIFE is oversold. This indicates that LIFE price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 0 indicates that LIFE is oversold. This indicates that LIFE price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 0 indicates that LIFE is oversold. This suggests that LIFE price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 0 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 0 indicates that LIFE is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term LIFE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Atyr Pharma Inc financial reports and earnings history, Atyr Pharma Inc (LIFE) stock could reach $5.7922 by 2030, $4.7767 by 2040 and $11.54 by 2050. See the projected annual prices until 2050 of the Atyr Pharma Inc stock below:
- Atyr Pharma Inc (LIFE) is expected to reach an average price of $2.1844 in 2035, with a high prediction of $2.2512 and a low estimate of $2.2544. This indicates an $-87.04% rise from the last recorded price of $16.85.
- Atyr Pharma Inc (LIFE) stock is projected to chart a bullish course in 2040, with an average price target of $4.7591, representing an $-71.76% surge from its current level. The forecast ranges from a conservative $4.7991 to a sky-high $4.7767.
- Our analysts predict Atyr Pharma Inc (LIFE) to jump -50.69% by 2045, soaring from $8.039 to an average price of $8.3087, potentially reaching $8.1021. While $8.039 is the low estimate, the potential upside is significant.
- Atyr Pharma Inc (LIFE) stock is expected to climb by 2050, reaching an average of $11.35, a $-32.61% jump from its current level. However, a wide range of estimates exists, with high and low targets of $11.54 and $11.71, respectively, highlighting the market's uncertainty.
Atyr Pharma Inc Stock (LIFE) Year by Year Forecast
Atyr Pharma Inc Stock (LIFE) Price Forecast for 2026
The predicted value for Atyr Pharma Inc (LIFE) in 2026 is set at an average of $4.6958. Estimates vary from a peak of $9.3571 to a trough of $0.0345, indicating an -72.13% surge from the present price of $16.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2026 | $0.3348 | $0.4048 | $2.8294 | -98.01% |
| March, 2026 | $0.3413 | $0.3789 | $0.2272 | -97.97% |
| April, 2026 | $1.218 | $0.4955 | $4.0321 | -92.77% |
| May, 2026 | $1.3914 | $0.0345 | $2.0914 | -91.74% |
| June, 2026 | $0.3448 | $0.0552 | $1.5973 | -97.95% |
| July, 2026 | $0.3959 | $0.1726 | $0.3207 | -97.65% |
| August, 2026 | $0.7376 | $0.0708 | $0.9276 | -95.62% |
| September, 2026 | $0.8268 | $0.1993 | $1.131 | -95.09% |
| October, 2026 | $0.8503 | $0.3186 | $0.8986 | -94.95% |
| November, 2026 | $1.7087 | $0.662 | $1.8137 | -89.86% |
| December, 2026 | $5.343 | $1.3754 | $9.3571 | -68.29% |
Atyr Pharma Inc Stock (LIFE) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Atyr Pharma Inc (LIFE) is $3.1364, with a high forecast of $6.2706 and a low forecast of $0.00226. This indicates an -81.39% decrease from the last price of $16.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.8564 | $4.5147 | $6.2706 | -71.18% |
| February, 2027 | $4.5999 | $4.4599 | $5.6081 | -72.70% |
| March, 2027 | $4.4792 | $3.9816 | $5.2433 | -73.42% |
| April, 2027 | $3.2426 | $3.0226 | $4.7767 | -80.76% |
| May, 2027 | $2.236 | $1.8443 | $3.3984 | -86.73% |
| June, 2027 | $1.6953 | $1.4736 | $2.5664 | -89.94% |
| July, 2027 | $2.0987 | $1.227 | $3.3529 | -87.54% |
| August, 2027 | $1.1322 | $1.0622 | $2.7346 | -93.28% |
| September, 2027 | $0.2685 | $0.1903 | $1.278 | -98.41% |
| October, 2027 | $0.4051 | $0.3327 | $0.2651 | -97.60% |
| November, 2027 | $0.2433 | $0.2016 | $0.2683 | -98.56% |
| December, 2027 | $0.6376 | $0.00226 | $0.9675 | -96.22% |
Atyr Pharma Inc Stock (LIFE) Price Forecast for 2028
In 2028, Atyr Pharma Inc (LIFE) is projected to reach an average price of $0.7078, with a high projection of $1.3935 and a low estimate of $0.0222. This indicates an -95.80% fall from the last price of $16.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.611 | $0.451 | $1.3935 | -96.37% |
| February, 2028 | $0.2245 | $0.0773 | $0.9428 | -98.67% |
| March, 2028 | $0.2262 | $0.0397 | $0.3103 | -98.66% |
| April, 2028 | $0.4878 | $0.2904 | $0.3828 | -97.11% |
| May, 2028 | $0.4135 | $0.3511 | $0.4219 | -97.55% |
| June, 2028 | $0.1001 | $0.2701 | $0.3477 | -99.41% |
| July, 2028 | $0.2267 | $0.1442 | $0.1233 | -98.65% |
| August, 2028 | $0.4074 | $0.2608 | $0.2141 | -97.58% |
| September, 2028 | $0.1889 | $0.2339 | $0.3238 | -98.88% |
| October, 2028 | $0.0705 | $0.2905 | $0.2723 | -99.58% |
| November, 2028 | $0.1788 | $0.0222 | $0.5111 | -98.94% |
| December, 2028 | $0.0822 | $0.0664 | $0.3464 | -99.51% |
Atyr Pharma Inc Stock (LIFE) Price Forecast for 2029
The 2029 price forecast for Atyr Pharma Inc Stock (LIFE) is $1.5972 on average, with a high prediction of $3.1676 and a low estimate of $0.0269. This represents an -90.52% decrease from the previous price of $16.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.0385 | $0.0385 | $0.1781 | -99.77% |
| February, 2029 | $0.0851 | $0.0553 | $0.0774 | -99.50% |
| March, 2029 | $0.1816 | $0.2033 | $0.1633 | -98.92% |
| April, 2029 | $0.4182 | $0.2558 | $0.2983 | -97.52% |
| May, 2029 | $0.6089 | $0.5123 | $0.4906 | -96.39% |
| June, 2029 | $0.3955 | $0.4455 | $0.503 | -97.65% |
| July, 2029 | $0.192 | $0.262 | $0.3638 | -98.86% |
| August, 2029 | $0.0723 | $0.0283 | $0.1073 | -99.57% |
| September, 2029 | $0.4507 | $0.0269 | $0.6569 | -97.33% |
| October, 2029 | $0.57 | $0.1541 | $0.77 | -96.62% |
| November, 2029 | $0.2834 | $0.2634 | $0.7258 | -98.32% |
| December, 2029 | $4.3254 | $0.2395 | $3.1676 | -74.33% |
Atyr Pharma Inc Stock (LIFE) Price Forecast for 2030
Atyr Pharma Inc Stock (LIFE) is expected to reach an average price of $6.4478 in 2030, with a high forecast of $8.1751 and a low forecast of $4.7204. This signifies an -61.73% decrease from the last price of $16.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $6.4222 | $5.4991 | $5.7922 | -61.89% |
| February, 2030 | $6.5954 | $6.6388 | $6.2554 | -60.86% |
| March, 2030 | $8.2385 | $7.7636 | $7.9085 | -51.11% |
| April, 2030 | $8.2816 | $8.3816 | $8.1751 | -50.85% |
| May, 2030 | $7.5631 | $7.5248 | $8.1599 | -55.12% |
| June, 2030 | $7.2255 | $7.5862 | $7.6396 | -57.12% |
| July, 2030 | $6.5875 | $7.1876 | $7.1528 | -60.91% |
| August, 2030 | $6.6023 | $6.3742 | $6.4407 | -60.82% |
| September, 2030 | $4.6933 | $5.3839 | $6.3573 | -72.15% |
| October, 2030 | $6.4253 | $4.7204 | $6.1353 | -61.87% |
| November, 2030 | $7.7584 | $6.4536 | $6.5284 | -53.96% |
| December, 2030 | $7.3016 | $7.4833 | $7.3267 | -56.67% |
0.89%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):